Skip to main content
UNC Lineberger's Thomas Alexander, MD, MPH, and colleagues have published research findings that could lead to better treatment for a rare blood cancer in children that has features of both acute myeloid leukemia and acute lymphoblastic leukemia.

September 13, 2018

Findings could improve treatment for challenging acute leukemia in children

There is no consensus on the best way to treat mixed phenotype acute leukemia, a rare blood cancer with survival rates of between 47 and 75 percent for children. Researchers from St. Jude Children’s Research Hospital and the University of North Carolina Lineberger Comprehensive Cancer Center, led by Thomas Alexander, MD, MPH, have made important discoveries about the genetics of this disease that could lead to better treatments.